RxDoctor Payments Data

Martin Schreiber, MD

Surgery · Tacoma, WANPI 1831105386

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (36.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by CSL Behring at 48.1% of the total. Reporting peaked in 2020 at $23,087 and has fallen 99.4% since, to $131 in 2025. Among surgery clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$41,630in general payments, 2019–2025

Across 64 payments — averaging $650.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$20K
  • Haemonetics Corporation$18K
  • Z-medica, LLC$2K
  • Cerus Corporation$750
  • Access Pro Medical, LLC$131
  • Aroa Biosurgery Incorporated$101
  • plus $265 from 4 others
$2,354,446in research payments, 2019–2025

Across 68 payments — averaging $34,624 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • CSL Behring$2.3M
  • Haemonetics Corporation$26K
  • Octapharma USA, Inc.$21K
  • AstraZeneca$11K

What the payments were for

  • Consulting fees$14,98236%
  • Speaking & faculty fees$14,65535%
  • Travel & lodging$10,12624%
  • Food & beverage$1,8674%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$41,630 in reported general payments places this provider in the 95th percentile of 549 surgery providers in Washington.

See all surgery providers in Washington

Medicare billing

Part B allowed, 2024
$6,334
Medicare patients
32
Services billed
45

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgery in Tacoma

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →